Strive Asset Management has raised $750 million to pursue the strategy while Ramaswamy runs to be Ohio’s governor.

Biotech execs express concerns over FDA changes, NIH cuts, and Trump's tariffs. Industry confidence low amid poor funding ...

In this era of escalating trade tensions and geopolitical uncertainty, the U.S. cannot afford to cede another critical ...

This week ended up as a pretty active one for large startup financings. AI and biotech were the biggest areas for funding, ...

The key to biotech is finding companies with lots of cash and promising ... a market value under $200 million—compared with about $100 million of cash. Jefferies analyst Maury Raycroft favors ...

Pfizer will produce the drug, which targets lung and colorectal cancers, in the US and take a US$100 million stake in China’s ...

Discover the key biotech trends moving the industry forward in Europe at a time when there lies uncertainty in global ...

Western drugmakers, investors increasingly aim to acquire Chinese compounds.